Treace Medical Concepts/$TMCI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Ticker
$TMCI
Sector
Primary listing
Employees
450
Headquarters
Website
TMCI Metrics
BasicAdvanced
$254m
-
-$0.96
1.11
-
Price and volume
Market cap
$254m
Beta
1.11
52-week high
$7.78
52-week low
$1.17
Average daily volume
641k
Financial strength
Current ratio
3.58
Quick ratio
2.395
Long term debt to equity
89.869
Total debt to equity
92.762
Interest coverage (TTM)
-9.99%
Profitability
EBITDA (TTM)
-47.678
Gross margin (TTM)
79.72%
Net profit margin (TTM)
-29.44%
Operating margin (TTM)
-26.89%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
-17.87%
Return on equity (TTM)
-66.88%
Valuation
Price to revenue (TTM)
1.205
Price to book
3.29
Price to tangible book (TTM)
4.42
Price to free cash flow (TTM)
-9.625
Free cash flow yield (TTM)
-10.39%
Free cash flow per share (TTM)
-0.407
Growth
Revenue change (TTM)
-1.66%
Earnings per share change (TTM)
12.29%
3-year revenue growth (CAGR)
10.18%
3-year earnings per share growth (CAGR)
4.47%
What the Analysts think about TMCI
Analyst ratings (Buy, Hold, Sell) for Treace Medical Concepts stock.
TMCI Financial Performance
Revenues and expenses
TMCI Earnings Performance
Company profitability
TMCI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs